These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7138066)

  • 61. [Orientation on genetic screening for cystic fibrosis].
    Brandt NJ; Schwartz M; Skovby F
    Ugeskr Laeger; 1991 May; 153(19):1365-8. PubMed ID: 2042248
    [No Abstract]   [Full Text] [Related]  

  • 62. Costs and benefits of prenatal screening for cystic fibrosis.
    Garber AM; Fenerty JP
    Med Care; 1991 May; 29(5):473-89. PubMed ID: 1673488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CF screening.
    Vassart G; Cochaux P; Abramowicz M
    Nature; 1990 Feb; 343(6259):586. PubMed ID: 2334486
    [No Abstract]   [Full Text] [Related]  

  • 64. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Transparent Approach to Calculate Detection Rate and Residual Risk for Carrier Screening.
    Leung ML; McAdoo S; Watson D; Stumm K; Harr M; Wang X; Chung CH; Mafra F; Nesbitt AI; Hakonarson H; Santani A
    J Mol Diagn; 2021 Jan; 23(1):91-102. PubMed ID: 33349347
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.
    Bruni T; Mameli M; Pravettoni G; Boniolo G
    Med Health Care Philos; 2012 Aug; 15(3):321-8. PubMed ID: 21863402
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening for carriers of cystic fibrosis.
    Raeburn S
    BMJ; 1994 Jun; 308(6942):1451-2. PubMed ID: 8019273
    [No Abstract]   [Full Text] [Related]  

  • 68. Screening for cystic fibrosis carriers.
    Brock DJ
    Lancet; 1992 Oct; 340(8825):984. PubMed ID: 1357397
    [No Abstract]   [Full Text] [Related]  

  • 69. Principles and practicalities of carrier screening: attitudes of recent parents.
    Green JM
    J Med Genet; 1992 May; 29(5):313-9. PubMed ID: 1583658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implications of carrier identification in newborn screening for cystic fibrosis.
    Parsons EP; Clarke AJ; Bradley DM
    Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F467-71. PubMed ID: 14602692
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Screening for cystic fibrosis: a four year regional experience.
    Roberts G; Stanfield M; Black A; Redmond A
    Arch Dis Child; 1988 Dec; 63(12):1438-43. PubMed ID: 3232990
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prenatal genetics: the evolution and future directions of screening and diagnosis.
    Slack C; Lurix K; Lewis S; Lichten L
    J Perinat Neonatal Nurs; 2006; 20(1):93-7. PubMed ID: 16508474
    [No Abstract]   [Full Text] [Related]  

  • 73. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis.
    Sawyer SM; Cerritelli B; Carter LS; Cooke M; Glazner JA; Massie J
    Pediatrics; 2006 Sep; 118(3):e649-56. PubMed ID: 16950956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.
    Langfelder-Schwind E; Kloza E; Sugarman E; Pettersen B; Brown T; Jensen K; Marcus S; Redman J;
    J Genet Couns; 2005 Feb; 14(1):1-15. PubMed ID: 15789152
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Active cascade cystic fibrosis screening.
    Super M; Haworth A; Schwarz MJ
    Prenat Diagn; 1995 Nov; 15(11):1082-3. PubMed ID: 8606890
    [No Abstract]   [Full Text] [Related]  

  • 77. Cystic fibrosis: the new genetics.
    Brock DJ; Shrimpton AE; Jones C; McIntosh I
    J R Soc Med; 1991; 84 Suppl 18(Suppl 18):2-6. PubMed ID: 2033572
    [No Abstract]   [Full Text] [Related]  

  • 78. Cystic fibrosis: prospects for screening and therapy.
    Lancet; 1990 Jan; 335(8681):79-80. PubMed ID: 1688641
    [No Abstract]   [Full Text] [Related]  

  • 79. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis.
    Scotet V; de Braekeleer M; Roussey M; Rault G; Parent P; Dagorne M; Journel H; Lemoigne A; Codet JP; Catheline M; David V; Chaventré A; Duguépéroux I; Verlingue C; Quéré I; Mercier B; Audrézet MP; Férec C
    Lancet; 2000 Sep; 356(9232):789-94. PubMed ID: 11022925
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening for cystic fibrosis.
    Lancet; 1991 Dec; 338(8781):1524-5. PubMed ID: 1683943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.